JAK1 and Ewing sarcoma: These data suggest that chemotherapeutics induce JAK1 activation in Ewing sarcoma to phosphorylate STAT6-Y641, triggering its transcriptional activation of GAS6, which activates TAM/Akt/ERK signaling and enhances chemoresistance in an autocrine or/and paracrine manner.